Glynium Respicap
1 Packet of 30 Respicaps.Prescription required
About this product:
| Salt Composition: | Glycopyrrolate (50mcg) |
| Manufacturer: | Zydus Healthcare Limited |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Glynium Respicap is used to treat chronic obstructive pulmonary disease (COPD) by relaxing the muscles around the lungs and reducing symptoms like coughing, chest tightness, and shortness of breath. Glynium Respicap is an anticholinergic medication used for long-term management of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD). It works by blocking the activity of a chemical messenger (acetylcholine) in the brain. Your doctor will tell you how often you need to use Glynium Respicap. It is important that you take the lowest dose needed to effectively control your symptoms. The effect of this medicine may be noticeable after a few days but will only reach its maximum after a few weeks. This medicine must be used regularly to be effective, so continue using it even if you do not have any symptoms. If you stop taking it, your symptoms of COPD may get worse.
Glynium Respicap is an anticholinergic medication. It works by blocking the activity of a chemical messenger (acetylcholine) in the brain.
Is Glynium Respicap a steroid?
No, Glynium Respicap is not a steroid. It belongs to a class of medicines called bronchodilators that are used to widen the airway of the respiratory tract. These medications help ease breathing difficulties in patients with breathing problems caused by certain types of lung disease like obstructive pulmonary disease (COPD).
How long should I take Glynium Respicap?
The duration of treatment depends on the severity and type of the condition. For chronic obstructive pulmonary disease (COPD), a long-term condition, it's important to take this medicine daily as prescribed by your doctor to prevent attacks of breathing difficulties. It should be taken consistently even when you don't have breathing problems or other symptoms of COPD.
Can Glynium Respicap inhalation cause difficulty urinating?
Inhalational Glynium Respicap can lead to urinary retention and difficulty urinating in older individuals, especially men with enlarged prostates or benign prostate enlargement. This condition can cause difficulties urinating, including painful urination, frequent urination, dribbling, or a feeling of incomplete emptying. If you experience any such symptoms before or during treatment, it's important to notify your doctor.
Can Glynium Respicap inhalation cause vision problems?
Inhaling Glynium Respicap can lead to blurred vision and even acute narrow-angle glaucoma. This medicine can trigger eye pain, discomfort, nausea or vomiting, blurred vision, seeing halos or bright colors around lights, and red eyes. If you experience any of these symptoms, immediately discontinue the medication and contact your doctor immediately.
Use this medicine in the dose and duration as advised by your doctor. Check the label for directions before use.
- Glynium Respicap is used for long-term management of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD).
- It does not work right away and should not be used to relieve sudden breathing problems.
- Take the first dose of this medicine under medical supervision as it may cause wheezing or tightening of the airways (bronchospasm) immediately after using.
- Avoid getting this medication into your eyes. It may cause eye pain/irritation, temporary blurred vision, and other vision changes.
- Inform your doctor if you have difficulty passing urine or have painful urination.
Alcohol
It is not known whether it is safe to consume alcohol with Glynium Respicap. Please consult your doctor.
Breastfeed
Glynium Respicap is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby. Long-term use of Glynium Respicap might reduce milk production.
Pregnancy
Glynium Respicap is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.